Evidence map›Paper›PMID 37789081›Full record

ArticleScientific reports2023

Whole genome sequencing of increased number of azithromycin-resistant Shigella flexneri 1b isolates in Ontario.

Alefiya Neemuchwala, Sandra Zittermann, Karen Johnson, Dean Middleton, Patrick J Stapleton, Vithusha Ravirajan, Kirby Cronin, Vanessa G Allen, Samir N Patel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of azithromycin-resistantMicrobiology spectrum · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alefiya NeemuchwalaOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Sandra ZittermannOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Karen JohnsonOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Dean MiddletonOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Patrick J StapletonOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Vithusha RavirajanOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Kirby CroninOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Vanessa G AllenOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada.
Samir N PatelOntario Agency for Health Protection and Promotion (Public Health Ontario), Toronto, ON, Canada. Samir.Patel@oahpp.ca.
Public Health Ontario · CAMount Sinai Hospital · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azithromycin (AZM) resistance among Shigella is a major public health concern. Here, we investigated the epidemiology of Shigella flexneri serotype 1b recovered during 2016-2018 in Ontario, to describe the prevalence and spread of AZM resistance. We found that 72.3% (47/65) of cases were AZM-resistant (AZM

Indexed as

AzithromycinDysentery, BacillaryAnti-Bacterial AgentsCiprofloxacinDrug Resistance, BacterialHumansMaleMicrobial Sensitivity TestsNeisseria gonorrhoeaeOntarioPhylogenyShigella flexneriWhole Genome SequencingAnti-Bacterial AgentsAzithromycinCiprofloxacin

Identifiers

PMID37789081
PMCPMC10547750
OpenAlexW4387312286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.